By enhancing the expression of key molecules in the TLR signaling pathway, particularly the TRAM-TRIF-TNF receptor-associated factor 6 (TRAF6) axis, PSP modulates immune responses and may provide therapeutic benefits in gastric cancer by improving antitumor immunity165 (Figure 2 and Table 2). Here, TRAF6 is linked to gastric cancer.